2026 NPPES data Corneal and Contact Management Optometrist NPI 1962802439 O.D.
Verify on CMS →

CHERYL ZABROWSKI FLOGEL, O.D.

Corneal and Contact Management Optometrist in MINNEAPOLIS, Minnesota. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
246
Medicare Part D claims · 69 beneficiaries · Corneal and Contact Management Optometrist avg: 235
Generic prescribing
41%
generic claims · 59% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.3405/100
▼ 1 pts below national avg 83.1 · [object Object]
Industry payments
$188.06
4 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

CHERYL ZABROWSKI FLOGEL, O.D. reported a CMS MIPS final score of 82.3405/100 — below the 83.1 national average — and filed 246 Medicare Part D claims in 2023.

82.3405/100
MIPS score · -1 vs avg
246
Part D claims, 2023
41%
generic prescribing
$188.06
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

CHERYL ZABROWSKI FLOGEL, O.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

82 39th percentile higher than 39% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about CHERYL ZABROWSKI FLOGEL, O.D.?

Near national average

NPI registry status

Active

Issued 09/03/2014

NPI 1962802439

Primary specialty

Corneal and Contact Management Optometrist

Niche

1,549 US NPIs in this specialty

Medicare Part D claims

246 5% vs specialty avg

2023 prescription claims

Specialty avg: 235

MIPS final score

82.3405/100 0.7594999999999885% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Minnesota

How Corneal and Contact Management Optometrist compares to other specialties among Minnesota providers

Minnesota providers

Corneal and Contact Management Optometrist share within Minnesota

1. Corneal and Contact Management Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Corneal and Contact Management Optometrist share within Minnesota

Medicare quality performance — MIPS

CHERYL ZABROWSKI FLOGEL, O.D.'s 2023 MIPS final score plotted against the Corneal and Contact Management Optometrist national average

Near national average
MIPS Final Score
82.3405/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Corneal and Contact Management Optometrist) — 82.3405/100 vs national avg 83.1

0%100%National avg83%82.3%
MIPS final score (Corneal and Contact Management Optometrist) — 82.3405/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CHERYL ZABROWSKI FLOGEL, O.D. appears in the CMS NPPES registry as a Corneal and Contact Management Optometrist provider holding O.D. credentials at 516 DELAWARE ST SE, MINNEAPOLIS, MN, 55455, with a listed phone of (612) 625-4400. NPI 1962802439 was issued on 09/03/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ZABROWSKI FLOGEL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 246 prescription claims written by this provider, covering 69 Medicare beneficiaries and totaling roughly $67K in drug spend, split 59% brand-name and 41% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.3405/100 for the 2023 performance year (Quality 81.5407, Cost 38.1722), compared with the national average of 83.1.

Corneal and Contact Management Optometrist is a narrow specialty nationwide, with 1,549 enrolled providers across 52 states and an average of 235 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

516 DELAWARE ST SE
MINNEAPOLIS, MN 55455

Provider Details

NPI 1962802439
Specialty Corneal and Contact Management Optometrist
Credentials O.D.
Gender Female
NPI Issued 09/03/2014

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

82.3405
Final Score
Avg: 83.1
81.5407
Quality
38.1722
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where CHERYL ZABROWSKI FLOGEL, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

FAIRVIEW EXPRESS CARE
MINNEAPOLIS, MN
UNIVERSITY OF MINNESOTA HEALTH CLINICS AND SURGERY CENTER INC
MINNEAPOLIS, MN
UNIVERSITY OF MINNESOTA PHYSICIANS
MINNEAPOLIS, MN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CHERYL ZABROWSKI FLOGEL, O.D.. Source: openpaymentsdata.cms.gov.

Total received

$188

Largest payer

Glaukos Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

CHERYL ZABROWSKI FLOGEL, O.D. — brand share 59.0%
Specialty average (est.)

59% brand-name claims vs 41% generic, on 246 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

246
Total Claims
$67K
Total Drug Cost
69
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
322
Total Day Supply
8,220
Brand vs Generic
59% brand / 41% generic
Brand Drug Cost
$64K
Generic Drug Cost
$3K

Patient Demographics

Average Patient Age
69.7 years
Avg HCC Risk Score
1.64
Gender Split
75% female / 25% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What CHERYL ZABROWSKI FLOGEL, O.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Restasis
Cyclosporine
37
Latanoprost
32
Erythromycin
Erythromycin Base
26
Fluorometholone
22
Cyclosporine
19
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
18
Xiidra
Lifitegrast
16
Timolol Maleate
12
Prednisolone Acetate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Corneal and Contact Management Optometrist Overview

How CHERYL ZABROWSKI FLOGEL, O.D. fits within the Corneal and Contact Management Optometrist landscape nationally.

1,549
Corneal and Contact Management Optometrist Providers in US
52
States with Corneal and Contact Management Optometrist
235
Avg Claims per Provider

CHERYL ZABROWSKI FLOGEL, O.D.'s 246 claims are above the specialty average of 235.

Nearby Corneal and Contact Management Optometrist Providers in Minnesota

Other clinicians with the same primary specialty enrolled in Minnesota, drawn from the same CMS NPPES roster as ZABROWSKI FLOGEL.

Compare Corneal and Contact Management Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is CHERYL ZABROWSKI FLOGEL, O.D.'s specialty?
CHERYL ZABROWSKI FLOGEL, O.D. specializes in Corneal and Contact Management Optometrist and practices in MINNEAPOLIS, Minnesota. Credentials: O.D..
How much does CHERYL ZABROWSKI FLOGEL, O.D. prescribe under Medicare Part D?
In 2023, CHERYL ZABROWSKI FLOGEL, O.D. wrote 246 Medicare Part D claims totaling $67K in drug costs for 69 beneficiaries.
What is CHERYL ZABROWSKI FLOGEL, O.D.'s Medicare quality score?
CHERYL ZABROWSKI FLOGEL, O.D. has a CMS MIPS Final Score of 82.3405/100 (Quality: 81.5407, Cost: 38.1722). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is CHERYL ZABROWSKI FLOGEL, O.D. located?
CHERYL ZABROWSKI FLOGEL, O.D. is located at 516 DELAWARE ST SE, MINNEAPOLIS, MN, 55455. Phone: (612) 625-4400.
What is CHERYL ZABROWSKI FLOGEL, O.D.'s NPI number?
CHERYL ZABROWSKI FLOGEL, O.D.'s National Provider Identifier (NPI) is 1962802439, issued on 09/03/2014.
Does CHERYL ZABROWSKI FLOGEL, O.D. prescribe more brand-name or generic drugs?
CHERYL ZABROWSKI FLOGEL, O.D.'s prescribing is 59% brand-name and 41% generic drugs by claim count, with $64K in brand drug costs.
How many Corneal and Contact Management Optometrist providers are there in the US?
There are 1,549 Corneal and Contact Management Optometrist providers across 52 states in the US. The average Corneal and Contact Management Optometrist provider writes 235 Medicare Part D claims per year.
What drugs does CHERYL ZABROWSKI FLOGEL, O.D. prescribe most often?
Based on 2023 Medicare Part D data, CHERYL ZABROWSKI FLOGEL, O.D.'s most frequently prescribed drugs include Restasis, Latanoprost, Erythromycin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CHERYL ZABROWSKI FLOGEL, O.D. accept Medicare?
CHERYL ZABROWSKI FLOGEL, O.D. appears in CMS Medicare data with 246 Part D claims and 69 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CHERYL ZABROWSKI FLOGEL, O.D.'s credentials?
CHERYL ZABROWSKI FLOGEL, O.D.'s NPI is 1962802439 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology